Insights

NICE at 25: HTA Methods Guidelines – Evolution, not revolution

1 May 2024

OHE celebrates NICE’s 25 anniversary through a series of insights explaining NICE’s first steps and discussing NICE’s present and future role.

Plan For A New EU Pharmaceutical Legislation: What Will It Mean For Pharmaceutical Innovation?

12 April 2024

The European Commission and European Parliament have set out their proposals for a reformed EU pharmaceutical legislation which could substantially change the incentive ecosystem for the first time in 20 years.

Daniel Kahneman

Kahneman’s legacy in health economics

4 April 2024

Daniel Kahneman (1934 – 2024) was a Nobel Prize-winning psychologist known for his pioneering work in behavioural economics.

Rare Disease Day 2024: Why do we care about rare?

Rare Disease Day 2024: Why Do We Care About Rare?

29 February 2024

Rare Disease Day is observed on the last day of February every year, and today – February 29th – is truly the rarest day.

Looking Further Afield – What Can Health Economics Learn from the Environmental Economics Approach to Discounting?

1 February 2024

Discounting in economic evaluations presents challenges for therapies with high up-front costs and long-term benefits. We discuss how health economics can learn from debates occurring within environmental economics, where discounting poses similar challenges.

Around The World in HTAs: Türkiye – The bumpy road toward transformation

31 January 2024

In this Insights series, Around the World in HTAs, we shed light on HTA around the world. In this edition, Prof Hasan Huseyin Yildirim, Dilek Sernur Eminoğulları, Dr Tuba Saygın Avşar, and Patricia Cubi-Molla take us to Türkiye.

Navigating the Intersection of Healthcare and Environmental Sustainability: ISPOR Europe round-up on the inclusion of environmental impact in HTA

Navigating the Intersection of Healthcare and Environmental Sustainability: ISPOR Europe round-up on the inclusion of environmental impact in HTA

17 January 2024

In this insight, commissioned and funded by Chiesi S.p.A, we reflect on the discussions that took place at ISPOR Europe 2023 and how environmental impact is factored into HTA.

Breaking the European Deadlock: Part 3 – Revenue Guarantee and Subscription Models for New Antibiotics

16 January 2024

Insight 3 of this series provides an exploration of revenue guarantee/subscription models and how they could be implemented in the EU.

Could Plant-based Diets Transform Health Care Spending?

8 January 2024

In a bid to reduce health care budgets, policymakers and healthcare professionals are increasingly looking to prevention strategies.